147 related articles for article (PubMed ID: 34334739)
1. Brief Report: Yield of Repeat Tuberculin Skin Testing for People Living With HIV in Brazil.
Chaisson LH; Saraceni V; Cohn S; Cavalcante SC; Chaisson RE; Durovni B; Golub JE
J Acquir Immune Defic Syndr; 2021 Dec; 88(4):329-332. PubMed ID: 34334739
[TBL] [Abstract][Full Text] [Related]
2. CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.
Chaisson LH; Saraceni V; Cohn S; Seabrook D; Cavalcante SC; Chaisson RE; Golub JE; Durovni B
AIDS; 2020 Jan; 34(1):139-147. PubMed ID: 31634189
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.
Kerkhoff AD; Kranzer K; Samandari T; Nakiyingi-Miiro J; Whalen CC; Harries AD; Lawn SD
PLoS One; 2012; 7(11):e49928. PubMed ID: 23209621
[TBL] [Abstract][Full Text] [Related]
4. Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.
Huerga H; Mueller Y; Ferlazzo G; Mpala Q; Bevilacqua P; Vasquez B; Noël Mekiedje C; Ouattara A; Mchunu G; Weyenga HO; Varaine F; Bonnet M
J Acquir Immune Defic Syndr; 2016 Apr; 71(4):e89-95. PubMed ID: 26910386
[TBL] [Abstract][Full Text] [Related]
5. Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.
Golub JE; Cohn S; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; Durovni B; Chaisson RE
Clin Infect Dis; 2015 Feb; 60(4):639-45. PubMed ID: 25365974
[TBL] [Abstract][Full Text] [Related]
6. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.
Durovni B; Cavalcante SC; Saraceni V; Vellozo V; Israel G; King BS; Cohn S; Efron A; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
AIDS; 2010 Nov; 24 Suppl 5(Suppl 5):S49-56. PubMed ID: 21079428
[TBL] [Abstract][Full Text] [Related]
7. Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.
Johnson DF; Malone LL; Zalwango S; Mukisa Oketcho J; Chervenak KA; Thiel B; Mayanja-Kizza H; Stein CM; Boom WH; Lancioni CL;
PLoS One; 2014; 9(5):e96613. PubMed ID: 24796677
[TBL] [Abstract][Full Text] [Related]
8. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
[TBL] [Abstract][Full Text] [Related]
9. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil.
Saraceni V; Pacheco AG; Golub JE; Vellozo V; King BS; Cavalcante SC; Eldred L; Chaisson RE; Durovni B
Braz J Infect Dis; 2011; 15(3):249-52. PubMed ID: 21670926
[TBL] [Abstract][Full Text] [Related]
10. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial.
Durovni B; Saraceni V; Moulton LH; Pacheco AG; Cavalcante SC; King BS; Cohn S; Efron A; Chaisson RE; Golub JE
Lancet Infect Dis; 2013 Oct; 13(10):852-8. PubMed ID: 23954450
[TBL] [Abstract][Full Text] [Related]
11. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
Sudre P; Rieder H; Bassetti S; Hirschel BJ; Ledergerber B; Malvy D
Schweiz Med Wochenschr; 1996 Nov; 126(47):2007-12. PubMed ID: 8984608
[TBL] [Abstract][Full Text] [Related]
12. INH preventive therapy among adult HIV-infected patients in Thailand.
Hiransuthikul N; Nelson KE; Hiransuthikul P; Vorayingyong A; Paewplot R
Int J Tuberc Lung Dis; 2005 Mar; 9(3):270-5. PubMed ID: 15786889
[TBL] [Abstract][Full Text] [Related]
13. Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda.
Kirenga BJ; Worodria W; Massinga-Loembe M; Nalwoga T; Manabe YC; Kestens L; Colebunders R; Mayanja-Kizza H
Int J Tuberc Lung Dis; 2013 Mar; 17(3):336-41. PubMed ID: 23407223
[TBL] [Abstract][Full Text] [Related]
14. Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials.
Ayele HT; Mourik MS; Debray TP; Bonten MJ
PLoS One; 2015; 10(11):e0142290. PubMed ID: 26551023
[TBL] [Abstract][Full Text] [Related]
15. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
Briggs MA; Emerson C; Modi S; Taylor NK; Date A
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
[TBL] [Abstract][Full Text] [Related]
16. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
[TBL] [Abstract][Full Text] [Related]
17. Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.
Smith T; Samandari T; Abimbola T; Marston B; Sangrujee N
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e84-93. PubMed ID: 26258564
[TBL] [Abstract][Full Text] [Related]
18. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
[TBL] [Abstract][Full Text] [Related]
19. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.
Khawcharoenporn T; Apisarnthanarak A; Manosuthi W; Sungkanuparph S; Mundy LM
Int J Tuberc Lung Dis; 2012; 16(3):336-41. PubMed ID: 22230143
[TBL] [Abstract][Full Text] [Related]
20. Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.
Danyuttapolchai J; Kittimunkong S; Nateniyom S; Painujit S; Klinbuayaem V; Maipanich N; Maokamnerd Y; Pevzner E; Whitehead S; Kanphukiew A; Monkongdee P; Martin M
PLoS One; 2017; 12(9):e0184986. PubMed ID: 28949995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
